about
Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinomaOmission of Chemotherapy in Early Stage Nasopharyngeal Carcinoma Treated with IMRT: A Paired Cohort Study.Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma.Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.Organ-sparing radiation therapy for head and neck cancer.Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck.The preliminary study of 18F-FLT micro-PET/CT in predicting radiosensitivity of human nasopharyngeal carcinoma xenografts.Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma.Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes.Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy.In reply to Abbasi et al.Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels.Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma.Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapyPatterns of level II node metastasis in nasopharyngeal carcinomaPreliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinomaRole of chemoradiotherapy in intermediate prognosis nasopharyngeal carcinomaTreatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiationCarcinoma of the nasopharynx in young patients: a single institution experienceRadiation-induced cranial nerve palsy: a cross-sectional study of nasopharyngeal cancer patients after definitive radiotherapyCetuximab in combination with chemoradiotherapy in the treatment of recurrent and/or metastatic nasopharyngeal carcinomaPrediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase (99m)Tc-MIBI SPECT/CTPreliminary results of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a retrospective study of 364 patients
P50
Q35114677-A6D45838-6AA5-4643-A2A4-F74F945FBAD2Q35137049-2606E57E-799B-48AE-B6E7-52EC464DB884Q36195727-3BCCE718-8F01-4BC5-9FA0-2A09A937428AQ37418009-BE4328F8-A600-4A08-8E44-D7FFA245E20FQ37607352-0675EC1C-844E-466F-8445-310BE4CFEC50Q37717594-56B756B4-FBAC-4F5B-A2C3-6E3C0995C4D3Q37905536-268F1A9A-1354-41D4-A3FE-5BF3D9AEF60FQ37972452-4ACE1AA1-8299-469E-A454-B3359E2DD9A3Q38957000-DB4091FF-92CB-4B95-94DB-61E814F15738Q41045761-A0A27A81-BCFA-4AD9-BC0B-7C22798EC510Q41451059-2ED2CB74-1D6A-4973-AA98-9E78FC04B103Q43632373-A589E9C4-E81F-48D7-A3A1-BF64B0A9F544Q43771934-310C93C8-D499-40E4-B6F0-997E4612A94FQ44532853-C16E7865-EE26-49B3-9991-B2CA3F4654ABQ44610961-A18AAFC7-22BB-4CFA-9F1B-F06C1CFA96F4Q45345259-A88380EF-F239-4285-84B3-5146E8928FF6Q46720860-4DB9A934-0759-4AD1-AE07-972C65EE5C65Q48290637-5116432A-57F2-4D93-9D01-DDA64B7EC903Q48634743-E24FC44E-FE8E-4BA5-8A6B-8E2683DA17C3Q50430866-89C026CC-E1E2-4C74-9999-EDCBDE4A50AFQ53422425-0860142E-294F-4CD4-87E4-DA387BE9D98DQ53591693-FC197DF3-8BDC-49FA-9497-4B2578081820Q54441344-3C6F7C7A-17F7-470C-8849-8720CE4B19C0Q79899743-9D3EB357-7D4C-4778-99F5-9CE4C3739044Q81924068-ED12ADBD-4B9F-459C-BA42-9C21809F595CQ83327747-E0DA825C-2885-4EE1-851F-0D895D27C8F3Q83769547-BFB1C547-3E72-46D2-A073-03F7E2C5262EQ84222855-435BF8A3-4FCB-460D-991C-B841D0E0DF34Q84364047-3EA571BA-44F4-43E6-87A4-15327D4B97FFQ84530505-4003465B-857F-41DE-8F8D-8FC6B6667D60Q86095873-869FDD42-815C-443E-A938-BF099F48C17BQ87055697-1C1F69DE-B863-40AB-BED7-CE3D88CBB7FFQ87306819-DF4F98D2-A52A-4447-81F6-D13E08DDF5D9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chaosu Hu
@ast
Chaosu Hu
@en
Chaosu Hu
@es
Chaosu Hu
@nl
Chaosu Hu
@sl
type
label
Chaosu Hu
@ast
Chaosu Hu
@en
Chaosu Hu
@es
Chaosu Hu
@nl
Chaosu Hu
@sl
prefLabel
Chaosu Hu
@ast
Chaosu Hu
@en
Chaosu Hu
@es
Chaosu Hu
@nl
Chaosu Hu
@sl
P106
P31
P496
0000-0001-7697-5224